Loading viewer...
earnings
Format: PDF earnings
Alnylam Pharmaceuticals presents third quarter 2016 financial results and corporate updates. The presentation covers Q3 overview, clinical pipeline developments, financial performance, and 2016 goal progress, along with forward-looking statements regarding drug discovery, regulatory approvals, and business strategy.
presentation
earnings
21 Pages
Action Construction Equipment Limited